Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSUVASTATIN vs ROTIGOTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROSUVASTATIN vs ROTIGOTINE: Safety Overview

Metric ROSUVASTATIN ROTIGOTINE
Total FAERS Reports 36,332 7,846
Deaths Reported 1,536 1,299
Death Rate 4.2% 16.6%
Hospitalizations 11,195 1,727
Average Patient Age 66.1 yrs 70.2 yrs
% Female Patients 54.9% 51.1%
FDA Approval Date Apr 1, 2020 Apr 2, 2012
Manufacturer Umedica Laboratories USA Inc. UCB, Inc.
Route ORAL TRANSDERMAL
Marketing Status Prescription Prescription